[1]
“A Regulatory NLP Framework for Evaluating Data Sufficiency in FDA Meeting Request Submissions”, Ind-Am. J Pharm. Bio. Sci., vol. 23, no. 4, pp. 1–13, Nov. 2025, doi: 10.62646/iajpb.2025.v23.i04.pp01-13.